Analogs of gastric inhibitory polypeptide and their use of treatment for diabetes
US7326688B2 · kind B2 · utility
39Cited by
2References
135Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2005 |
| Grant date | Feb 5, 2008 |
| Priority date | — |
| Expiry date | Jun 28, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides peptides which stimulate the release of insulin. The peptides, based on GIP 1-42 include substitutions and/or modifications which enhance and influence secretion and/or have enhanced resistance to degradation. The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.